According to the study of Li and colleagues, NLRP3 inflammasome activity was enhanced in the cardiomyocytes of patients with atrial fibrillation (most common cardiac arrhythmia) [102]. This evidence concerns the gene NLRP3 and cardiac rhythm disease.